Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
StandardStandard
Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence. / Hughes, D.; Hughes, D.A.; Dubois, D.
Yn: Pharmacoeconomics, Cyfrol 22, Rhif 16, 01.01.2004, t. 1047-1059.
Yn: Pharmacoeconomics, Cyfrol 22, Rhif 16, 01.01.2004, t. 1047-1059.
Allbwn ymchwil: Cyfraniad at gyfnodolyn › Erthygl › adolygiad gan gymheiriaid
HarvardHarvard
Hughes, D, Hughes, DA & Dubois, D 2004, 'Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence.', Pharmacoeconomics, cyfrol. 22, rhif 16, tt. 1047-1059.
APA
Hughes, D., Hughes, D. A., & Dubois, D. (2004). Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence. Pharmacoeconomics, 22(16), 1047-1059.
CBE
Hughes D, Hughes DA, Dubois D. 2004. Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence. Pharmacoeconomics. 22(16):1047-1059.
MLA
Hughes, D., D.A. Hughes a D. Dubois. "Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence.". Pharmacoeconomics. 2004, 22(16). 1047-1059.
VancouverVancouver
Hughes D, Hughes DA, Dubois D. Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence. Pharmacoeconomics. 2004 Ion 1;22(16):1047-1059.
Author
RIS
TY - JOUR
T1 - Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence.
AU - Hughes, D.
AU - Hughes, D.A.
AU - Dubois, D.
PY - 2004/1/1
Y1 - 2004/1/1
KW - PHARMACOLOGY & PHARMACY
M3 - Article
VL - 22
SP - 1047
EP - 1059
JO - Pharmacoeconomics
JF - Pharmacoeconomics
SN - 1170-7690
IS - 16
ER -